Takeda Pharmaceutical Co Adr (TAK)

Mar 31, 2025

TAK vs. DSNKY: Which Stock Should Value Investors Buy Now? - Yahoo

Mar 31, 2025

Mar 26, 2025

[Latest] Global Fabry Disease Treatment Market Size/Share Worth USD 7.02 Billion by 2034 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.

Mar 26, 2025

Mar 14, 2025

PD Stock on the Rise: A Promising Investment - The InvestChronicle

Mar 14, 2025

Mar 14, 2025

TAK or DSNKY: Which Is the Better Value Stock Right Now? - Yahoo Finance

Mar 14, 2025

Mar 14, 2025

Vital Energy Inc (VTLE) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

Mar 14, 2025

Mar 14, 2025

China Liberal Education Holdings Ltd: A Comprehensive Look at the Stock’s Ups and Downs - The InvestChronicle

Mar 14, 2025

Mar 14, 2025

Takeda Pharmaceutical Stock (NYSE: TAK): Strategic Focus on Oncology and Growth Opportunities - Value the Markets

Mar 14, 2025

Mar 13, 2025

Takeda: Buy Into Future Drug Pipeline Potential, Despite Recent Profit Headwinds - Seeking Alpha

Mar 13, 2025

Mar 10, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Mar 10, 2025

Mar 06, 2025

Charles Schwab Trying To Close In On Key Technical Measure - Inkl

Mar 06, 2025

Mar 04, 2025

Takeda Pharmaceutical Co ADR (TAK) Stock: A Year of Highs and Lows in the Market - The InvestChronicle

Mar 04, 2025

Mar 04, 2025

Takeda Pharmaceutical ADR Trying To Close In On Key Technical Measure - Inkl

Mar 04, 2025

Feb 18, 2025

XFOR: Receives €28.5 Upfront for Licensing Agreement with Norgine… - MSN

Feb 18, 2025

Feb 17, 2025

TAK vs. DSNKY: Which Stock Is the Better Value Option? - Nasdaq

Feb 17, 2025

Feb 15, 2025

Ex-Intern Becomes Billionaire in Australia Pharmacy Merger - MSN

Feb 15, 2025

Feb 15, 2025

Vyvanse Leaks: Beyond The Headlines - Truth or Fiction

Feb 15, 2025

Feb 14, 2025

IgA nephropathy Clinical Trials and Pipeline 2025: EMA, PDMA, - openPR

Feb 14, 2025

Feb 13, 2025

IgA nephropathy Clinical Trials and Pipeline Assessment: EMA, - openPR

Feb 13, 2025

Feb 10, 2025

Procter & Gamble Co (PG) expanding its growth trajectory ahead - SETE News

Feb 10, 2025

Feb 10, 2025

Prepare Yourself for Liftoff: AMKOR Technology Inc (AMKR) - SETE News

Feb 10, 2025

Feb 07, 2025

Takeda Pharmaceutical Co ADR [TAK] President, Plasma-Derived Ther makes an insider purchase of 19,073 shares worth 0.28 million. – Knox Daily - Knox Daily

Feb 07, 2025

Feb 07, 2025

Advanced Drainage Systems Inc [WMS] Records 50-Day SMA of $122.78 - Knox Daily

Feb 07, 2025

Feb 07, 2025

GFL Shares Experience Surge in Value - Knox Daily

Feb 07, 2025

Feb 07, 2025

UBS Group AG [UBS] Shares Rise 2.39 % on Thursday - Knox Daily

Feb 07, 2025

Feb 07, 2025

Takeda Pharmaceutical Co ADR (TAK)’s stock price range in the last year - US Post News

Feb 07, 2025

Feb 05, 2025

Inmode Ltd (INMD) Stock Price and Analyst Predictions - The News Heater

Feb 05, 2025

Feb 03, 2025

Recent Insider Activity Could Benefit Wabash National Corp (WNC) - Knox Daily

Feb 03, 2025

Feb 03, 2025

Analyzing Takeda Pharmaceutical Co ADR (TAK) After Recent Trading Activity - Knox Daily

Feb 03, 2025

Jan 30, 2025

Takeda signals 2025 growth with raised guidance, JPY 100B buyback, and new leadership transition - MSN

Jan 30, 2025

Jan 27, 2025

Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World - Dealbreaker

Jan 27, 2025

Jan 21, 2025

Keros Therapeutics seals $200M deal with Takeda - Investing.com

Jan 21, 2025

Jan 15, 2025

Japan’s Takeda launches innovation centre in Bengaluru; to hire 750 in 2025 - Deccan Herald

Jan 15, 2025

Jan 14, 2025

Weekly Upgrades and Downgrades - InvestorPlace

Jan 14, 2025

Jan 02, 2025

Amgen stock price formed a death cross: will it rebound in 2025? - MSN

Jan 02, 2025

Dec 30, 2024

Takeda-backed Ascentage Pharma files for $100M IPO (IPO:NYSEARCA) - Seeking Alpha

Dec 30, 2024